Life Sciences BPO Market Size, Share & Trends Analysis Report By Service (Medical Devices Outsourcing, Pharmaceutical Outsourcing), By Region (North America, APAC), And Segment Forecasts, 2022 - 2030
This report can be delivered to the clients within 3 Business Days
Life Sciences BPO Market Growth & Trends
The global life sciences BPO market size is expected to reach USD 827.5 billion by 2030, registering a CAGR of 9.2% over the forecast years, according to a new report by Grand View Research, Inc. The rising costs of drug development; pre-clinical and clinical trials; and post-marketing surveillance; a rise in the patent cliff; a growing product pipeline; and regulatory constraints are some of the major factors driving the market. The pharmaceutical and biotech industries invest heavily in the R&D sector to continuously introduce new molecules, devices, and treatments. The different stages of drug development, such as drug discovery, pre-clinical studies, and clinical trials, require huge financial, technological, and human resources.
To cater to the growing needs of the industry, the outsourcing vendors are expanding their product and service offerings and they are targeting niche areas for long-term growth and profitability. Altogether, these trends are expected to boost the life sciences outsourcing market over the forecast period. During the COVID-19 pandemic, a significant number of outsourcing providers expanded their existing manufacturing and research facilities to meet the growing demand for COVID-19 vaccines and diagnostics. Even post-pandemic, CDMOs are practicing similar strategies to support the future demand for pharmaceuticals. For instance, in April 2022, Aenova Group developed a new facility for manufacturing highly potent drugs with an investment of EUR 10 million.
The adoption of such strategies by the market players is expected to be profitable for the market. There has been a rising demand to reduce the cost of manufacturing and development of drugs and medical devices. Outsourcing manufacturing, research, and marketing services provide pharmaceutical and medical device companies with cost- and time-saving benefits. This is expected to have a positive impact on the market. Over the years, mergers and acquisition deals between CROs and CDMOs have increased. The rising demand for clinical services and the growing need for specialized service providers to improve the focus on their core competencies are some of the factors that are expected to drive the incidence of M&A deals.
Life Sciences BPOMarket Report Highlights
Life Sciences BPO Market Growth & Trends
The global life sciences BPO market size is expected to reach USD 827.5 billion by 2030, registering a CAGR of 9.2% over the forecast years, according to a new report by Grand View Research, Inc. The rising costs of drug development; pre-clinical and clinical trials; and post-marketing surveillance; a rise in the patent cliff; a growing product pipeline; and regulatory constraints are some of the major factors driving the market. The pharmaceutical and biotech industries invest heavily in the R&D sector to continuously introduce new molecules, devices, and treatments. The different stages of drug development, such as drug discovery, pre-clinical studies, and clinical trials, require huge financial, technological, and human resources.
To cater to the growing needs of the industry, the outsourcing vendors are expanding their product and service offerings and they are targeting niche areas for long-term growth and profitability. Altogether, these trends are expected to boost the life sciences outsourcing market over the forecast period. During the COVID-19 pandemic, a significant number of outsourcing providers expanded their existing manufacturing and research facilities to meet the growing demand for COVID-19 vaccines and diagnostics. Even post-pandemic, CDMOs are practicing similar strategies to support the future demand for pharmaceuticals. For instance, in April 2022, Aenova Group developed a new facility for manufacturing highly potent drugs with an investment of EUR 10 million.
The adoption of such strategies by the market players is expected to be profitable for the market. There has been a rising demand to reduce the cost of manufacturing and development of drugs and medical devices. Outsourcing manufacturing, research, and marketing services provide pharmaceutical and medical device companies with cost- and time-saving benefits. This is expected to have a positive impact on the market. Over the years, mergers and acquisition deals between CROs and CDMOs have increased. The rising demand for clinical services and the growing need for specialized service providers to improve the focus on their core competencies are some of the factors that are expected to drive the incidence of M&A deals.
Life Sciences BPOMarket Report Highlights
- The increasing number of M&A transactions has broadened the global reach and improved the capabilities of CROs and CDMOs to provide end-to-end services; a continuation of this trend is expected to benefit the market significantly
- COVID-19 incidence has decreased significantly as a result of a growing global vaccination campaign
- Owing to this, the CRO and CDMO are now refocusing on developing drugs for oncology and other diseases owing to their high burden
- For instance, in April 2022, Labcorp collaborated with Xcell Biosciences to support the company in developing cell and gene therapies for treating cancer, Parkinson’s, and other rare diseases
- Such initiatives by the CDMOs are likely to profit the market owing to the high effectiveness of gene therapy in treating cancer and other rare diseases
- The medical device segment is expected to register the fastest CAGR from 2022 to 2030 due to the complexities associated with medical device designing
- The strict regulatory framework for medical device approval globally has further contributed to the demand for medical device outsourcing services
- Asia Pacific held the largest revenue share in 2021 due to the presence of a significant number of CROs providing cost-effective BPO services
CHAPTER 1. METHODOLOGY AND SCOPE
1.1 Market Segmentation & Scope
1.1.1 Regional Scope
1.1.2 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Gvr’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.2 Volume Price Analysis (Model 2)
1.7 List Of Secondary Sources
1.8 List Of Primary Sources
1.9 List Of Abbreviations
1.10 Objectives
1.10.1 Objective - 1:
1.10.2 Objective - 2:
1.10.3 Objective - 3:
1.10.4 Objective - 4:
CHAPTER 2. EXECUTIVE SUMMARY
2.1 Market Outlook
CHAPTER 3. LIFE SCIENCES BPO MARKET: VARIABLES, TRENDS, & SCOPE
3.1 Segment Outlook
3.2 Penetration & Growth Prospect Mapping
3.3 Market Dynamics
3.3.1 Market Driver Analysis
3.3.1.1 Growing Demand For Outsourcing Owing To The Cost Benefits Associated With Outsourcing
3.3.1.2 Growth In The Global R&D Spending On Pharmaceutical And Medical Devices.
3.3.1.3 Rise In The Number Of Clinical Studies In The Previous Years
3.3.2 Market Restraint Analysis
3.2.2.1 Limited Outsourcing By Established Companies
3.2.2.2 Quality Issues Associated WithCdmo Services
3.4 Life Sciences BPO Market Analysis Tools
3.4.1 Porter’s Five Forces Analysis
3.4.2 Pestel Analysis
3.4.3 Major Deals & Strategic Alliances Analysis
3.5 Covid-19 Impact Analysis
CHAPTER 4. LIFE SCIENCES BPO MARKET: SERVICE SEGMENT ANALYSIS
4.1 Definitions & Scope
4.2 Life Sciences BPO Market: Service Share Analysis, 2021 & 2030
4.3 Pharmaceutical Outsourcing
4.3.1 Pharmaceutical Outsourcing Market, 2018 - 2030 (USD Million)
4.3.2 Contract Manufacturing Market
4.3.2.1 Contract Manufacturing Market, 2018 - 2030 (USD Million)
4.3.2.2 API
4.3.2.2.1 API Market, 2018 - 2030 (USD Million)
4.3.2.3 Finished Dose Form
4.3.2.3.1 Finished Dose Form Market, 2018 - 2030 (USD Million)
4.3.2.4 Packaging
4.3.2.4.1Packaging Market, 2018 - 2030 (USD Million)
4.3.3 Contract Research Organizations
4.3.3.1 Drug Discovery
4.3.3.1.1 Drug Discovery Market, 2018 - 2030 (USD Million)
4.3.3.2 Preclinical Studies
4.3.3.2.1 Preclinical Studies Market, 2018 - 2030 (USD Million)
4.3.3.3 Clinical Trial Studies
4.3.3.3.1 Clinical Trial Studies Market, 2018 - 2030 (USD Million)
4.3.3.4 Regulatory Services
4.3.3.4.1 Regulatory Services Market, 2018 - 2030 (USD Million)
4.3.3.5 Pharmacovigilance
4.3.3.5.1 Pharmacovigilance Market, 2018 - 2030 (USD Million)
4.4 Medical Devices Outsourcing
4.4.1 Medical Devices Outsourcing Market, 2018 - 2030 (USD Million)
4.4.2 Contract Manufacturing
4.4.2.1 Contract Manufacturing Market, 2018 - 2030 (USD Million)
4.4.2.2 Electronic Manufacturing Services
4.4.2.2.1 Electronic Manufacturing Services market, 2018 - 2030 (USD Million)
4.4.2.3 Finished Goods
4.4.2.3.1 Finished Goods Market, 2018 - 2030 (USD Million)
4.4.2.4 Raw Materials/ Components
4.4.2.4.1 Raw Materials/ Components Market, 2018 - 2030 (USD Million)
4.5.2 Contract Research Organizations
4.4.2.1 Contract Research Organizations, 2018 - 2030 (USD Million)
4.4.2.2 Regulatory Consulting Services
4.4.2.2.1 Regulatory Consulting Services Market, 2018 - 2030 (USD Million)
4.4.2.3 Product Design And Development Services
4.4.2.3.1 Product Design And Development Services Market, 2018 - 2030 (USD Million)
4.4.2.4 Product Testing Services
4.4.2.4.1 Product Testing Services Market, 2018 - 2030 (USD Million)
4.4.2.5 Product Implementation Services
4.4.2.5.1Product Implementation Services Market, 2018 - 2030 (USD Million)
4.4.2.6 Product Upgrade Services
4.4.2.6.1 Product Upgrade Services Market, 2018 - 2030 (USD Million)
4.4.2.7 Product Maintenance Services
4.4.2.7.1 Product Maintenance Services Market, 2018 - 2030 (USD Million)
4.5 Contract Sales & Marketing Outsourcing
4.5.1 Contract Sales And Marketing Outsourcing Market, 2018 - 2030 (USD Million)
4.6 Others
4.6.1 Others Market, 2018 - 2030 (USD Million)
CHAPTER 5. LIFE SCIENCES BPO MARKET: REGIONAL ANALYSIS
5.1 Life Sciences BPO Market: Regional Share Analysis, 2021 & 2030
5.2 North America
5.2.1 North America Life Sciences BPO Market, 2018 - 2030 (USD Million)
5.2.2 U.S.
5.2.2.1 U.S. Life Sciences BPO Market, 2021 - 2030 (USD Million)
5.2.3 Canada
5.2.3.1 Canada Life Sciences BPO Market, 2018 - 2030 (USD Million)
5.3 Europe
5.3.1 Europe Life Sciences BPO Market, 2018 - 2030 (USD Million)
5.3.2 U.K.
5.3.2.1 U.K. Life Sciences BPO Market, 2018 - 2030 (USD Million)
5.3.3 Germany
5.3.3.1 Germany Life Sciences BPO Market, 2018 - 2030 (USD Million)
5.4 Asia Pacific
5.4.1 Asia Pacific Life Sciences BPO Market Estimates And Forecasts, 2018 - 2030
5.4.2 Japan
5.4.2.1 Japan Life Sciences BPO Market Estimates And Forecasts, 2018 - 2030
5.4.3 China
5.4.3.1 China Life Sciences BPO Market Estimates And Forecasts, 2018 - 2030
5.4.4 India
5.4.4.1 India Life Sciences BPO Market Estimates And Forecasts, 2018 - 2030
5.5 Latin America
5.5.1 Latin America Life Sciences BPO Market Estimates And Forecasts, 2018 - 2030
5.5.2 Brazil
5.5.2.1 Brazil Life Sciences BPO Market Estimates And Forecasts, 2018 - 2030
5.5.3 Mexico
5.5.3.1 Mexico Life Sciences BPO Market Estimates And Forecasts,2018 - 2030
5.6 MEA
5.6.1 MEA Life Sciences BPO Market Estimates And Forecasts, 2018 - 2030
5.6.2 South Africa
5.6.2.1 South Africa Life Sciences BPO Market Estimates And Forecasts, 2018 - 2030
CHAPTER 6. COMPANY PROFILES
6.1 Company Profiles
6.1.1 Atos Se
6.1.1.1 Company Overview
6.1.1.2 Financial Performance
6.1.1.3 Service Benchmarking
6.1.1.4 Strategic Initiatives
6.1.2 Boehringer Ingelheim Gmbh
6.1.2.1 Company Overview
6.1.2.2 Financial Performance
6.1.2.3 Service Benchmarking
6.1.3 Catalent, Inc.
6.1.3.1 Company Overview
6.1.3.2 Financial Performance
6.1.3.3 Service Benchmarking
6.1.3.4 Strategic Initiatives
6.1.4 Covance (Labcorp)
6.1.4.1 Company Overview
6.1.4.2 Financial Performance
6.1.4.3 Service Benchmarking
6.1.4.4 Strategic Initiatives
6.1.5 Genpact Limited
6.1.5.1 Company Overview
6.1.5.2 Financial Performance
6.1.5.3 Service Benchmarking
6.1.5.4 Strategic Initiatives
6.1.6 Icon Plc
6.1.6.1 Company Overview
6.1.6.2 Financial Performance
6.1.6.3 Service Benchmarking
6.1.6.4 Strategic Initiatives
6.1.7 Infosys Limited
6.1.7.1 Company Overview
6.1.7.2 Financial Performance
6.1.7.3 Service Benchmarking
6.1.7.4 Strategic Initiatives
6.1.8 International Business Machines Corporation
6.1.8.1 Company Overview
6.1.8.2 Financial Performance
6.1.8.3 Service Benchmarking
6.8.1.8.4 Strategic Initiatives
6.1.9 Lonza Group
6.1.9.1 Company Overview
6.1.9.2 Financial Performance
6.1.9.3 Service Benchmarking
6.1.9.4 Strategic Initiatives
6.1.10 Parexel International Corporation
6.1.10.1 Company Overview
6.1.10.2 Financial Performance
6.1.10.3 Service Benchmarking
6.1.10.4 Strategic Initiatives
6.1.11 Iqvia
6.1.11.1 Company Overview
6.1.11.2 Financial Performance
6.1.11.3 Service Benchmarking
6.1.11.4 Strategic Initiatives
1.1 Market Segmentation & Scope
1.1.1 Regional Scope
1.1.2 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Gvr’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.2 Volume Price Analysis (Model 2)
1.7 List Of Secondary Sources
1.8 List Of Primary Sources
1.9 List Of Abbreviations
1.10 Objectives
1.10.1 Objective - 1:
1.10.2 Objective - 2:
1.10.3 Objective - 3:
1.10.4 Objective - 4:
CHAPTER 2. EXECUTIVE SUMMARY
2.1 Market Outlook
CHAPTER 3. LIFE SCIENCES BPO MARKET: VARIABLES, TRENDS, & SCOPE
3.1 Segment Outlook
3.2 Penetration & Growth Prospect Mapping
3.3 Market Dynamics
3.3.1 Market Driver Analysis
3.3.1.1 Growing Demand For Outsourcing Owing To The Cost Benefits Associated With Outsourcing
3.3.1.2 Growth In The Global R&D Spending On Pharmaceutical And Medical Devices.
3.3.1.3 Rise In The Number Of Clinical Studies In The Previous Years
3.3.2 Market Restraint Analysis
3.2.2.1 Limited Outsourcing By Established Companies
3.2.2.2 Quality Issues Associated WithCdmo Services
3.4 Life Sciences BPO Market Analysis Tools
3.4.1 Porter’s Five Forces Analysis
3.4.2 Pestel Analysis
3.4.3 Major Deals & Strategic Alliances Analysis
3.5 Covid-19 Impact Analysis
CHAPTER 4. LIFE SCIENCES BPO MARKET: SERVICE SEGMENT ANALYSIS
4.1 Definitions & Scope
4.2 Life Sciences BPO Market: Service Share Analysis, 2021 & 2030
4.3 Pharmaceutical Outsourcing
4.3.1 Pharmaceutical Outsourcing Market, 2018 - 2030 (USD Million)
4.3.2 Contract Manufacturing Market
4.3.2.1 Contract Manufacturing Market, 2018 - 2030 (USD Million)
4.3.2.2 API
4.3.2.2.1 API Market, 2018 - 2030 (USD Million)
4.3.2.3 Finished Dose Form
4.3.2.3.1 Finished Dose Form Market, 2018 - 2030 (USD Million)
4.3.2.4 Packaging
4.3.2.4.1Packaging Market, 2018 - 2030 (USD Million)
4.3.3 Contract Research Organizations
4.3.3.1 Drug Discovery
4.3.3.1.1 Drug Discovery Market, 2018 - 2030 (USD Million)
4.3.3.2 Preclinical Studies
4.3.3.2.1 Preclinical Studies Market, 2018 - 2030 (USD Million)
4.3.3.3 Clinical Trial Studies
4.3.3.3.1 Clinical Trial Studies Market, 2018 - 2030 (USD Million)
4.3.3.4 Regulatory Services
4.3.3.4.1 Regulatory Services Market, 2018 - 2030 (USD Million)
4.3.3.5 Pharmacovigilance
4.3.3.5.1 Pharmacovigilance Market, 2018 - 2030 (USD Million)
4.4 Medical Devices Outsourcing
4.4.1 Medical Devices Outsourcing Market, 2018 - 2030 (USD Million)
4.4.2 Contract Manufacturing
4.4.2.1 Contract Manufacturing Market, 2018 - 2030 (USD Million)
4.4.2.2 Electronic Manufacturing Services
4.4.2.2.1 Electronic Manufacturing Services market, 2018 - 2030 (USD Million)
4.4.2.3 Finished Goods
4.4.2.3.1 Finished Goods Market, 2018 - 2030 (USD Million)
4.4.2.4 Raw Materials/ Components
4.4.2.4.1 Raw Materials/ Components Market, 2018 - 2030 (USD Million)
4.5.2 Contract Research Organizations
4.4.2.1 Contract Research Organizations, 2018 - 2030 (USD Million)
4.4.2.2 Regulatory Consulting Services
4.4.2.2.1 Regulatory Consulting Services Market, 2018 - 2030 (USD Million)
4.4.2.3 Product Design And Development Services
4.4.2.3.1 Product Design And Development Services Market, 2018 - 2030 (USD Million)
4.4.2.4 Product Testing Services
4.4.2.4.1 Product Testing Services Market, 2018 - 2030 (USD Million)
4.4.2.5 Product Implementation Services
4.4.2.5.1Product Implementation Services Market, 2018 - 2030 (USD Million)
4.4.2.6 Product Upgrade Services
4.4.2.6.1 Product Upgrade Services Market, 2018 - 2030 (USD Million)
4.4.2.7 Product Maintenance Services
4.4.2.7.1 Product Maintenance Services Market, 2018 - 2030 (USD Million)
4.5 Contract Sales & Marketing Outsourcing
4.5.1 Contract Sales And Marketing Outsourcing Market, 2018 - 2030 (USD Million)
4.6 Others
4.6.1 Others Market, 2018 - 2030 (USD Million)
CHAPTER 5. LIFE SCIENCES BPO MARKET: REGIONAL ANALYSIS
5.1 Life Sciences BPO Market: Regional Share Analysis, 2021 & 2030
5.2 North America
5.2.1 North America Life Sciences BPO Market, 2018 - 2030 (USD Million)
5.2.2 U.S.
5.2.2.1 U.S. Life Sciences BPO Market, 2021 - 2030 (USD Million)
5.2.3 Canada
5.2.3.1 Canada Life Sciences BPO Market, 2018 - 2030 (USD Million)
5.3 Europe
5.3.1 Europe Life Sciences BPO Market, 2018 - 2030 (USD Million)
5.3.2 U.K.
5.3.2.1 U.K. Life Sciences BPO Market, 2018 - 2030 (USD Million)
5.3.3 Germany
5.3.3.1 Germany Life Sciences BPO Market, 2018 - 2030 (USD Million)
5.4 Asia Pacific
5.4.1 Asia Pacific Life Sciences BPO Market Estimates And Forecasts, 2018 - 2030
5.4.2 Japan
5.4.2.1 Japan Life Sciences BPO Market Estimates And Forecasts, 2018 - 2030
5.4.3 China
5.4.3.1 China Life Sciences BPO Market Estimates And Forecasts, 2018 - 2030
5.4.4 India
5.4.4.1 India Life Sciences BPO Market Estimates And Forecasts, 2018 - 2030
5.5 Latin America
5.5.1 Latin America Life Sciences BPO Market Estimates And Forecasts, 2018 - 2030
5.5.2 Brazil
5.5.2.1 Brazil Life Sciences BPO Market Estimates And Forecasts, 2018 - 2030
5.5.3 Mexico
5.5.3.1 Mexico Life Sciences BPO Market Estimates And Forecasts,2018 - 2030
5.6 MEA
5.6.1 MEA Life Sciences BPO Market Estimates And Forecasts, 2018 - 2030
5.6.2 South Africa
5.6.2.1 South Africa Life Sciences BPO Market Estimates And Forecasts, 2018 - 2030
CHAPTER 6. COMPANY PROFILES
6.1 Company Profiles
6.1.1 Atos Se
6.1.1.1 Company Overview
6.1.1.2 Financial Performance
6.1.1.3 Service Benchmarking
6.1.1.4 Strategic Initiatives
6.1.2 Boehringer Ingelheim Gmbh
6.1.2.1 Company Overview
6.1.2.2 Financial Performance
6.1.2.3 Service Benchmarking
6.1.3 Catalent, Inc.
6.1.3.1 Company Overview
6.1.3.2 Financial Performance
6.1.3.3 Service Benchmarking
6.1.3.4 Strategic Initiatives
6.1.4 Covance (Labcorp)
6.1.4.1 Company Overview
6.1.4.2 Financial Performance
6.1.4.3 Service Benchmarking
6.1.4.4 Strategic Initiatives
6.1.5 Genpact Limited
6.1.5.1 Company Overview
6.1.5.2 Financial Performance
6.1.5.3 Service Benchmarking
6.1.5.4 Strategic Initiatives
6.1.6 Icon Plc
6.1.6.1 Company Overview
6.1.6.2 Financial Performance
6.1.6.3 Service Benchmarking
6.1.6.4 Strategic Initiatives
6.1.7 Infosys Limited
6.1.7.1 Company Overview
6.1.7.2 Financial Performance
6.1.7.3 Service Benchmarking
6.1.7.4 Strategic Initiatives
6.1.8 International Business Machines Corporation
6.1.8.1 Company Overview
6.1.8.2 Financial Performance
6.1.8.3 Service Benchmarking
6.8.1.8.4 Strategic Initiatives
6.1.9 Lonza Group
6.1.9.1 Company Overview
6.1.9.2 Financial Performance
6.1.9.3 Service Benchmarking
6.1.9.4 Strategic Initiatives
6.1.10 Parexel International Corporation
6.1.10.1 Company Overview
6.1.10.2 Financial Performance
6.1.10.3 Service Benchmarking
6.1.10.4 Strategic Initiatives
6.1.11 Iqvia
6.1.11.1 Company Overview
6.1.11.2 Financial Performance
6.1.11.3 Service Benchmarking
6.1.11.4 Strategic Initiatives
LIST OF TABLES
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Strategic initiatives in the Life Science BPO market
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Strategic initiatives in the Life Science BPO market
LIST OF FIGURES
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Market formulation & validation
Fig. 6 Commodity flow analysis
Fig. 7 Volume price analysis
Fig. 8 Life sciences BPO Market snapshot (2021) (USD Million)
Fig. 9 Life sciences BPO Market segmentation
Fig. 10 Penetration & growth prospect mapping
Fig. 11 Market driver relevance analysis (Current & future impact)
Fig. 12 Market restraint relevance analysis (Current & future impact)
Fig. 13 Porter’s five forces analysis
Fig. 14 SWOT analysis, by a factor (political & legal, economic and technological)
Fig. 15 Life sciences BPO market service outlook: Segment dashboard
Fig. 16 Life sciences BPO Market: Service movement analysis
Fig. 17 Pharmaceutical outsourcing Market
Fig. 18 Contract manufacturing market, 2018 - 2030 (USD Billion)
Fig. 19 Active pharmaceutical ingredients market 2018 - 2030 (USD Billion)
Fig. 20 Finished dose form market 2018 - 2030 (USD Billion)
Fig. 21 Packaging market 2018 - 2030 (USD Billion)
Fig. 22 Contract research organizations market 2018 - 2030 (USD Billion)
Fig. 23 Drug discovery market 2018 - 2030 (USD Billion)
Fig. 24 Preclinical studies market 2018 - 2030 (USD Billion)
Fig. 25 Clinical trial studies market 2018 - 2030 (USD Billion)
Fig. 26 Pharmacovigilance market 2018 - 2030 (USD Billion)
Fig. 27 Regulatory services market 2018 - 2030 (USD Billion)
Fig. 28 Medical devices outsourcing market 2018 - 2030 (USD Billion)
Fig. 29 Contract manufacturing services market 2018 - 2030 (USD Billion)
Fig. 30 Electronic manufacturing services market 2018 - 2030 (USD Billion)
Fig. 31 Finished goods market 2018 - 2030 (USD Billion)
Fig. 32 Raw materials/components market 2018 - 2030 (USD Billion)
Fig. 33 Regulatory consulting services market 2018 - 2030 (USD Billion)
Fig. 34 Product design and development services market 2018 - 2030 (USD Billion)
Fig. 35 Product testing services market 2018 - 2030 (USD Billion)
Fig. 36 Product implementation services market 2018 - 2030 (USD Billion)
Fig. 37 Product upgrade services market 2018 - 2030 (USD Billion)
Fig. 38 Product maintenance services market 2018 - 2030 (USD Billion)
Fig. 39 Contract sales and marketing organization market 2018 - 2030 (USD Billion)
Fig. 40 Regional Market Place: Key Takeaways
Fig. 41 Regional Outlook, 2021 & 2030
Fig. 42 North America, 2018 - 2030 (USD Billion)
Fig. 43 North America life sciences BPO market 2018 - 2030 (USD Billion)
Fig. 44 U.S. life sciences BPO market 2018 - 2030 (USD Billion)
Fig. 45 Canada life sciences BPO market 2018 - 2030 (USD Billion)
Fig. 46 Europe life sciences BPO market 2018 - 2030 (USD Billion)
Fig. 47 Germany life sciences BPO market 2018 - 2030 (USD Billion)
Fig. 48 U.K. life sciences BPO market 2018 - 2030 (USD Billion)
Fig. 49 Asia-Pacific life sciences BPO market 2018 - 2030 (USD Billion)
Fig. 50 Japan life sciences BPO market 2018 - 2030 (USD Billion)
Fig. 51 China life sciences BPO market 2018 - 2030 (USD Billion)
Fig. 52 India life sciences BPO market 2018 - 2030 (USD Billion)
Fig. 53 Latin America life sciences BPO market 2018 - 2030 (USD Billion)
Fig. 54 Brazil life sciences BPO market 2018 - 2030 (USD Billion)
Fig. 55 Mexico life sciences BPO market 2018 - 2030 (USD Billion)
Fig. 56 MEA life sciences BPO market 2018 - 2030 (USD Billion)
Fig. 57 South Africa life sciences BPO market 2018 - 2030 (USD Billion)
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Market formulation & validation
Fig. 6 Commodity flow analysis
Fig. 7 Volume price analysis
Fig. 8 Life sciences BPO Market snapshot (2021) (USD Million)
Fig. 9 Life sciences BPO Market segmentation
Fig. 10 Penetration & growth prospect mapping
Fig. 11 Market driver relevance analysis (Current & future impact)
Fig. 12 Market restraint relevance analysis (Current & future impact)
Fig. 13 Porter’s five forces analysis
Fig. 14 SWOT analysis, by a factor (political & legal, economic and technological)
Fig. 15 Life sciences BPO market service outlook: Segment dashboard
Fig. 16 Life sciences BPO Market: Service movement analysis
Fig. 17 Pharmaceutical outsourcing Market
Fig. 18 Contract manufacturing market, 2018 - 2030 (USD Billion)
Fig. 19 Active pharmaceutical ingredients market 2018 - 2030 (USD Billion)
Fig. 20 Finished dose form market 2018 - 2030 (USD Billion)
Fig. 21 Packaging market 2018 - 2030 (USD Billion)
Fig. 22 Contract research organizations market 2018 - 2030 (USD Billion)
Fig. 23 Drug discovery market 2018 - 2030 (USD Billion)
Fig. 24 Preclinical studies market 2018 - 2030 (USD Billion)
Fig. 25 Clinical trial studies market 2018 - 2030 (USD Billion)
Fig. 26 Pharmacovigilance market 2018 - 2030 (USD Billion)
Fig. 27 Regulatory services market 2018 - 2030 (USD Billion)
Fig. 28 Medical devices outsourcing market 2018 - 2030 (USD Billion)
Fig. 29 Contract manufacturing services market 2018 - 2030 (USD Billion)
Fig. 30 Electronic manufacturing services market 2018 - 2030 (USD Billion)
Fig. 31 Finished goods market 2018 - 2030 (USD Billion)
Fig. 32 Raw materials/components market 2018 - 2030 (USD Billion)
Fig. 33 Regulatory consulting services market 2018 - 2030 (USD Billion)
Fig. 34 Product design and development services market 2018 - 2030 (USD Billion)
Fig. 35 Product testing services market 2018 - 2030 (USD Billion)
Fig. 36 Product implementation services market 2018 - 2030 (USD Billion)
Fig. 37 Product upgrade services market 2018 - 2030 (USD Billion)
Fig. 38 Product maintenance services market 2018 - 2030 (USD Billion)
Fig. 39 Contract sales and marketing organization market 2018 - 2030 (USD Billion)
Fig. 40 Regional Market Place: Key Takeaways
Fig. 41 Regional Outlook, 2021 & 2030
Fig. 42 North America, 2018 - 2030 (USD Billion)
Fig. 43 North America life sciences BPO market 2018 - 2030 (USD Billion)
Fig. 44 U.S. life sciences BPO market 2018 - 2030 (USD Billion)
Fig. 45 Canada life sciences BPO market 2018 - 2030 (USD Billion)
Fig. 46 Europe life sciences BPO market 2018 - 2030 (USD Billion)
Fig. 47 Germany life sciences BPO market 2018 - 2030 (USD Billion)
Fig. 48 U.K. life sciences BPO market 2018 - 2030 (USD Billion)
Fig. 49 Asia-Pacific life sciences BPO market 2018 - 2030 (USD Billion)
Fig. 50 Japan life sciences BPO market 2018 - 2030 (USD Billion)
Fig. 51 China life sciences BPO market 2018 - 2030 (USD Billion)
Fig. 52 India life sciences BPO market 2018 - 2030 (USD Billion)
Fig. 53 Latin America life sciences BPO market 2018 - 2030 (USD Billion)
Fig. 54 Brazil life sciences BPO market 2018 - 2030 (USD Billion)
Fig. 55 Mexico life sciences BPO market 2018 - 2030 (USD Billion)
Fig. 56 MEA life sciences BPO market 2018 - 2030 (USD Billion)
Fig. 57 South Africa life sciences BPO market 2018 - 2030 (USD Billion)
